These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 18509278)

  • 1. Immunohistological detection of Parvovirus B19 capsid proteins in endomyocardial biopsies from dilated cardiomyopathy patients.
    Escher F; Kuhl U; Sabi T; Suckau L; Lassner D; Poller W; Schultheiss HP; Noutsias M
    Med Sci Monit; 2008 Jun; 14(6):CR333-338. PubMed ID: 18509278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parvovirus B19 profiles in patients presenting with acute myocarditis and chronic dilated cardiomyopathy.
    Escher F; Modrow S; Sabi T; Kühl U; Lassner D; Schultheiss HP; Noutsias M
    Med Sci Monit; 2008 Dec; 14(12):CR589-97. PubMed ID: 19043365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis.
    Kuethe F; Lindner J; Matschke K; Wenzel JJ; Norja P; Ploetze K; Schaal S; Kamvissi V; Bornstein SR; Schwanebeck U; Modrow S
    Clin Infect Dis; 2009 Dec; 49(11):1660-6. PubMed ID: 19863443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptive immune responses against parvovirus B19 in patients with myocardial disease.
    Lindner J; Noutsias M; Lassner D; Wenzel J; Schultheiss HP; Kuehl U; Modrow S
    J Clin Virol; 2009 Jan; 44(1):27-32. PubMed ID: 18980860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and quantity of the parvovirus B19 genome in endomyocardial biopsies from patients with suspected myocarditis or idiopathic left ventricular dysfunction.
    Klein RM; Jiang H; Niederacher D; Adams O; Du M; Horlitz M; Schley P; Marx R; Lankisch MR; Brehm MU; Strauer BE; Gabbert HE; Scheffold T; Gülker H
    Z Kardiol; 2004 Apr; 93(4):300-9. PubMed ID: 15085375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype-specific effects on left ventricular function in parvovirus B19-positive patients with dilated cardiomyopathy.
    Ruppert V; Meyer T; Balbach A; Richter A; Müller HH; Maisch B; Pankuweit S;
    J Med Virol; 2011 Oct; 83(10):1818-25. PubMed ID: 21837800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic Review of PCR Proof of Parvovirus B19 Genomes in Endomyocardial Biopsies of Patients Presenting with Myocarditis or Dilated Cardiomyopathy.
    Rigopoulos AG; Klutt B; Matiakis M; Apostolou A; Mavrogeni S; Noutsias M
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31216741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low level myocardial parvovirus B19 persistence is a frequent finding in patients with heart disease but unrelated to ongoing myocardial injury.
    Lotze U; Egerer R; Glück B; Zell R; Sigusch H; Erhardt C; Heim A; Kandolf R; Bock T; Wutzler P; Figulla HR
    J Med Virol; 2010 Aug; 82(8):1449-57. PubMed ID: 20572082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples.
    Beersma MF; Claas EC; Sopaheluakan T; Kroes AC
    J Clin Virol; 2005 Sep; 34(1):71-5. PubMed ID: 15985386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of parvovirus B19 nucleic acids and expression of viral VP1/VP2 antigen in human colon carcinoma.
    Li Y; Wang J; Zhu G; Zhang X; Zhai H; Zhang W; Wang W; Huang G
    Am J Gastroenterol; 2007 Jul; 102(7):1489-98. PubMed ID: 17459020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction.
    Kühl U; Pauschinger M; Noutsias M; Seeberg B; Bock T; Lassner D; Poller W; Kandolf R; Schultheiss HP
    Circulation; 2005 Feb; 111(7):887-93. PubMed ID: 15699250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic dilated cardiomyopathy and persistent viral infection: lack of association in a controlled study using a quantitative assay.
    Moimas S; Zacchigna S; Merlo M; Buiatti A; Anzini M; Dreas L; Salvi A; Di Lenarda A; Giacca M; Sinagra G
    Heart Lung Circ; 2012 Dec; 21(12):787-93. PubMed ID: 22901461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of viral genome in the myocardium: lack of prognostic and functional relevance in patients with acute dilated cardiomyopathy.
    Kuethe F; Sigusch HH; Hilbig K; Tresselt C; Glück B; Egerer R; Figulla HR
    Am Heart J; 2007 May; 153(5):850-8. PubMed ID: 17452164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of functional T-cell markers and T-cell receptor Vbeta repertoire in endomyocardial biopsies from patients presenting with acute myocarditis and dilated cardiomyopathy.
    Noutsias M; Rohde M; Göldner K; Block A; Blunert K; Hemaidan L; Hummel M; Blohm JH; Lassner D; Kühl U; Schultheiss HP; Volk HD; Kotsch K
    Eur J Heart Fail; 2011 Jun; 13(6):611-8. PubMed ID: 21422001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanism underlying B19 virus inactivation and comparison to other parvoviruses.
    Mani B; Gerber M; Lieby P; Boschetti N; Kempf C; Ros C
    Transfusion; 2007 Oct; 47(10):1765-74. PubMed ID: 17880601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of cardiac parvovirus B19 in myocarditis and dilated cardiomyopathy: review of the literature.
    Verdonschot J; Hazebroek M; Merken J; Debing Y; Dennert R; Brunner-La Rocca HP; Heymans S
    Eur J Heart Fail; 2016 Dec; 18(12):1430-1441. PubMed ID: 27748022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral load.
    Dennert R; Velthuis S; Schalla S; Eurlings L; van Suylen RJ; van Paassen P; Tervaert JW; Wolffs P; Goossens VJ; Bruggeman C; Waltenberger J; Crijns HJ; Heymans S
    Antivir Ther; 2010; 15(2):193-201. PubMed ID: 20386074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parvovirus B19 genome in endomyocardial biopsy specimen.
    Pankuweit S; Lamparter S; Schoppet M; Maisch B
    Circulation; 2004 Apr; 109(14):e179. PubMed ID: 15078808
    [No Abstract]   [Full Text] [Related]  

  • 19. A Novel Murine Model of Parvovirus Associated Dilated Cardiomyopathy Induced by Immunization with VP1-Unique Region of Parvovirus B19.
    Bogomolovas J; Šimoliūnas E; Rinkūnaitė I; Smalinskaitė L; Podkopajev A; Bironaitė D; Weis CA; Marx A; Bukelskienė V; Gretz N; Grabauskienė V; Labeit D; Labeit S
    Biomed Res Int; 2016; 2016():1627184. PubMed ID: 27812527
    [No Abstract]   [Full Text] [Related]  

  • 20. Parvovirus B19 DNA detectable in hearts of patients with dilated cardiomyopathy, but absent or inactive in blood.
    Russcher A; Verdonschot J; Molenaar-de Backer MWA; Heymans SRB; Kroes ACM; Zaaijer HL
    ESC Heart Fail; 2021 Aug; 8(4):2723-2730. PubMed ID: 33931945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.